Aubagio

Aubagio EU Backing Comes With Generic Worries
Seeking Alpha
Tue, 03/26/13 - 09:33 am
Aubagio
Europe
generics
Sanofi
MS
multiple sclerosis
Biogen, Baxter, Sanofi, Gilead Win EU Endorsements
Investors.com
Fri, 03/22/13 - 11:45 am
Biogen Idec
Baxter International
Sanofi
Gilead
Europe
BG-12
Tecfidera
Aubagio
HyQvia
Halozyme
Stribild
2013 Should Be Interesting for Multiple Sclerosis Drugs
Motley Fool
Thu, 01/3/13 - 11:39 am
MS
multiple sclerosis
Teva
Copaxone
Rebif
Pfizer
Merck KGaA
Biogen Idec
Avonex
Bayer
Betaseron
Novartis
Extavia
Sanofi
Tysabri
Aubagio
Elan
Gilenya
BG-12
Overnight success proves elusive for oral MS drugs
Fierce Pharma
Tue, 11/20/12 - 01:25 pm
multiple sclerosis
MS
Novartis
Gilenya
Sanofi
Aubagio
Genzyme presents second Phase III study of once-daily AUBAGIO
Yahoo/Fly on the Wall
Fri, 10/12/12 - 11:00 am
Genzyme
Aubagio
MS
multiple sclerosis
Battle Lines Drawn in the MS Market
Motley Fool
Wed, 09/26/12 - 10:56 am
multiple sclerosis
MS
BiogenIdec
BG-12
Sanofi
Aubagio
Gilenya
Novartis
Multiple sclerosis drugs seen gaining traction
Marketwatch
Fri, 09/21/12 - 11:32 am
MS
multiple sclerosis
BiogenIdec
BG-12
Aubagio
Sanofi
Sanofi: A Long-Term Winner On These FDA Approvals
Seeking Alpha
Thu, 09/20/12 - 10:58 am
Sanofi
FDA
Aubagio
Zaltrap
Aubagio approval sets Sanofi up with possible blockbuster
Fierce Pharma
Thu, 09/13/12 - 10:22 am
Aubagio
MS
multiple sclerosis
Genzyme
Sanofi
FDA Approves Genzyme’s AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis
Yahoo
Wed, 09/12/12 - 10:35 pm
FDA
Genzyme
Sanofi
Aubagio
MS
multiple sclerosis
Positive Data for Sanofi's Aubagio
Yahoo/Zacks.com
Mon, 06/4/12 - 10:56 am
Sanofi
Aubagio
Genzyme
multiple sclerosis
Sanofi Says MS Pill Aubagio Fails to Beat Rebif in Trial
Bloomberg
Tue, 12/20/11 - 10:23 am
Sanofi
MS
Aubagio
Rebif
multiple sclerosis
Merck KGaA
Sanofi Singles Out Top Pipeline Prospects, New Cost Cuts
Motley Fool
Tue, 09/6/11 - 12:17 pm
Sanofi
Genzyme
Kynamro
Visamerin/Mulsevo
Zaltrap
Lemtrada
Aubagio
Lyxumia

Pages